Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16285-74-8

Post Buying Request

16285-74-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16285-74-8 Usage

Uses

4-Aminothieno[3,2-d]pyrimidine is a useful research intermediate

Check Digit Verification of cas no

The CAS Registry Mumber 16285-74-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,2,8 and 5 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16285-74:
(7*1)+(6*6)+(5*2)+(4*8)+(3*5)+(2*7)+(1*4)=118
118 % 10 = 8
So 16285-74-8 is a valid CAS Registry Number.
InChI:InChI=1/C6H5N3S/c7-6-5-4(1-2-10-5)8-3-9-6/h1-3H,(H2,7,8,9)

16285-74-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name thieno[3,2-d]pyrimidin-4-amine

1.2 Other means of identification

Product number -
Other names 4-Aminothieno[3,2-d]pyrimidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16285-74-8 SDS

16285-74-8Downstream Products

16285-74-8Relevant articles and documents

Discovery and optimization of 1-(4-chloro-3-(trifluoromethyl)-phenyl)-3-(2-(amino)pyridin-3-yl)ureas as novel kdr kinase inhibitors

Jiao, Yu,Huang, Fei,Xu, Pengfei,Zhang, Yanmin,Yang, Shangyan,Zhang, Danfeng,Lu, Tao,Tang, Weifang

, p. 328 - 337 (2016/07/06)

Kinase insert Domain-containing Receptor (KDR) is one of the currently validated targets for anticancer drug discovery and development. Herein, a series of o-amino-arylurea derivatives have been synthesized and evaluated for their kinase inhibitory activity. The optimization on the basis of biological screening and molecular modeling resulted in obvious increase in KDR kinase inhibitory activity compared with the hit compound. Eventually, we identified a potent inhibitor 5a of 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(2-((quinolin-4-ylmethyl) amino)pyridin-3-yl)urea scaffold against KDR (IC50 = 0.0689 μM), which can serve as good starting point for further KDR inhibitor optimization and development.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16285-74-8